• (S)-(+)-Dimethindene maleate: Technical Guidance for M2 Anta

  2026-04-20

  (S)-(+)-Dimethindene maleate enables precise, receptor-selective pharmacological interrogation in autonomic regulation, cardiovascular, and respiratory research. It is not suitable for diagnostic, clinical, or long-term solution-based applications. Use is restricted to bench workflows that require high-purity, well-characterized M2 muscarinic receptor antagonists.

• HOXC8 Suppresses Pyroptosis in NSCLC via Caspase-1 Regulatio

  2026-04-20

  This study reveals that HOXC8 functions as a transcriptional repressor of caspase-1, thereby preventing pyroptotic cell death in non-small cell lung carcinoma (NSCLC). The findings highlight a novel epigenetic mechanism by which HOXC8 and HDAC1/2 interaction controls inflammasome-mediated cell fate, with potential implications for targeting tumor immunity and cell death pathways.

• Ziprasidone Augmentation in Escitalopram-Treated Anxious Dep

  2026-04-19

  The referenced study rigorously evaluated ziprasidone augmentation in patients with major depressive disorder (MDD) and comorbid anxiety who had incomplete response to escitalopram. Findings suggest that ziprasidone provided equal antidepressant efficacy in both anxious and nonanxious subgroups, but clinically meaningful anxiolytic benefit was not observed. These results inform the nuanced understanding of SSRI augmentation strategies in complex depression profiles.

• Halazone: Applied Workflows for Antimicrobial Sulfonamide De

  2026-04-18

  Halazone stands out as a dual-action antimicrobial sulfonamide derivative, uniquely bridging high-precision water disinfection and neuronal sodium channel research. This article delivers actionable protocols, troubleshooting strategies, and advanced application insights, empowering researchers to maximize performance in microbiology and neurophysiology with APExBIO’s Halazone.

• MAPK10-Mediated KRT16 Degradation Suppresses NSCLC Metastasi

  2026-04-17

  This study uncovers how MAPK10 phosphorylation of keratin 16 triggers its ubiquitination and degradation, thereby restraining non-small cell lung cancer (NSCLC) metastasis. The findings illuminate a new regulatory axis with prognostic and therapeutic potential in NSCLC progression.

• Strategic Inhibition of NF-κB: BMS-345541 in Translational R

  2026-04-16

  This article examines the mechanistic and strategic landscape of BMS-345541 (free base) as a selective IKK-1/IKK-2 inhibitor, highlighting its pivotal role in modulating NF-κB signaling for inflammation and cancer research. Drawing on recent findings and best practices, it provides actionable guidance for translational researchers aiming to harness precise NF-κB pathway inhibition in preclinical models.

• Dibutyryl-cAMP, Sodium Salt: Precision Tools for Neuronal Co

  2026-04-15

  Discover how Dibutyryl-cAMP, sodium salt enables highly controlled cAMP signaling pathway research and advances the efficiency of fibroblast-to-neuron conversion. This deep-dive explores unique mechanistic insights and practical assay optimizations for experimental neuroscience.

• GluN2A/B Subunits Regulate Connexins in TMJ Inflammatory All

  2026-04-14

  This study uncovers how N-methyl-D-aspartate receptor (NMDAR) subunits GluN2A and GluN2B mediate the expression of connexins and pannexins in the trigeminal ganglion during temporomandibular joint (TMJ) inflammation. By elucidating their distinct regulatory roles and intracellular signaling pathways, the work identifies new molecular targets for managing orofacial inflammatory allodynia.

• MG-262 (Z-Leu-Leu-Leu-B(OH)2): Next-Gen Proteasome Inhibitio

  2026-04-13

  MG-262 (Z-Leu-Leu-Leu-B(OH)2) offers precise, reversible proteasome inhibition for apoptosis and cell cycle research, with robust protocols for both in vitro and in vivo workflows. Its solubility profile and selectivity empower researchers to dissect proteostasis mechanisms underlying muscle aging, osteoclast differentiation, and more.

• Exemestane (SKU A1296): Reliable Aromatase Inhibition in Bre

  2026-04-12

  This scenario-driven guide examines Exemestane (SKU A1296) as a selective, irreversible steroidal aromatase inhibitor for cell-based breast cancer assays. Drawing on workflow pain points and evidence-backed recommendations, it details how Exemestane from APExBIO addresses reproducibility, assay sensitivity, and protocol optimization for estrogen biosynthesis inhibition.

• HEY2 Represses Mitochondrial Genes to Control Cardiac Homeos

  2026-04-12

  This study uncovers how the transcriptional repressor HEY2 directly impairs mitochondrial oxidative respiration in cardiomyocytes, driving heart failure phenotypes. By mapping the HEY2/HDAC1–Ppargc1/Cpt regulatory axis, the research clarifies a conserved mechanism of metabolic control in cardiac health with implications for heart failure therapy.

• Oseltamivir Acid: Influenza Neuraminidase Inhibitor in Trans

  2026-04-11

  Oseltamivir acid stands out as a rigorously validated influenza neuraminidase inhibitor, offering reproducible performance in both virology and oncology assay platforms. This guide details advanced workflows, resistance management strategies, and troubleshooting tips that leverage APExBIO's trusted quality for research success.

• Halazone: Antimicrobial Sulfonamide Derivative for Water & N

  2026-04-11

  Halazone stands apart as both a rapid water disinfection agent and a precision modulator of neuronal sodium channels, leveraging dual pathways to serve antimicrobial and neurophysiological research. This article details real-world setup strategies, troubleshooting advice, and experimental enhancements to maximize Halazone’s utility in diverse laboratory settings.

• Pan-Caspase Inhibition as a Translational Strategy: Mecha...

  2026-04-10

  Q-VD-OPh, a potent and irreversible pan-caspase inhibitor from APExBIO, is transforming translational research in apoptosis, neurodegeneration, and cell viability enhancement. This article delivers a comprehensive, mechanistically grounded perspective on the strategic deployment of Q-VD-OPh (SKU A1901) for dissecting caspase signaling pathways, optimizing experimental models, and advancing therapeutic discovery. Drawing on recent high-impact findings and scenario-driven guidance, we articulate how pan-caspase inhibition is enabling researchers to bridge the gap between fundamental cell death mechanisms and next-gen translational applications—including novel approaches for senescence, cryopreservation, and neurodegeneration.

• SB202190 (FHPI): Scenario-Driven Best Practices for MAPK ...

  2026-04-09

  This evidence-based guide explores practical laboratory scenarios where SB202190 (FHPI) (SKU A1632) delivers superior reproducibility and selectivity for p38 MAPK pathway inhibition. Addressing real-world assay challenges, it provides actionable insights for cell viability and apoptosis research, linking to protocols and peer-reviewed data that support reliable experimental outcomes.

406 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page